Ohne eingeschaltetes JavaScript können Sie PSIAC nicht in vollem Umfang nutzen.
Literaturverzeichnis
Patsalos PN. Clin Pharmacokinet. Dec 2013; 52(12): 1045-61
Pubmed [9248]
Patsalos PN. Clin Pharmacokinet. Nov 2013; 52(11): 927-66
Pubmed [9258]
Patsalos PN. Epilepsia. Jan 2015; 56(1): 12-27
Pubmed [339]
Patsalos PN. Epilepsia. Jul 2008; 49(7): 1239-76
Pubmed [742]
Patsalos PN. Gen Pharmacol. Jan 1984; 15(1): 7-12
Pubmed [9295]
Patsalos PN. Lancet Neurol. Aug 2003; 2(8): 473-81
Pubmed [3669]
Patsalos PN. Ther Drug Monit. Oct 2018; 40(5): 526-548
Pubmed [5058]
Patsalos, Antiseizure Medication Interactions, Springer. [14012]
Pattanawongsa A. Drug Metab Dispos. Oct 2015; 43(10): 1468-76
Pubmed [9007]
Patterson BD. Ann Pharmacother. Nov 1994; 28(11): 1303-4
Pubmed [757]
Patterson HA. Brain Res. Feb 1976; 102(2): 323-8
Pubmed [3048]
Patterson JF. Stevens-Johnson syndrome associated with carbamazepine. Clin Psychopharmacol (1985) 5, 185 [847]
Patterson LH. Curr Pharm Des. Jan 2002; 8(15): 1335-47
Pubmed [13879]
Patwardhan RV. Hepatology. Mar 1983; 3(2): 248-53
Pubmed [790]
Paul B. Am J Health Syst Pharm. Sep 2008; 65(18): 1703-10
Pubmed [14030]
Pauli-Magnus C. Naunyn Schmiedebergs Arch Pharmacol. Dec 2001; 364(6): 551-7
Pubmed [4667]
Pauli-Magnus C. Naunyn Schmiedebergs Arch Pharmacol. Mar 2001; 363(3): 337-43
Pubmed [4539]
Paulison B. Cardiovasc Toxicol. Dec 2010; 10(4): 306-10
Pubmed [3485]
Paulsen O. Eur J Clin Pharmacol. Jan 1987; 32(5): 493-8
Pubmed [5988]
Paulzen M. Br J Clin Pharmacol. Feb 2017
Pubmed [4335]
Paulzen M. Int J Neuropsychopharmacol. Feb 2007; 10(1): 149-51
Pubmed [3000]
Paulzen M. Int J Neuropsychopharmacol. Mar 2008; 11(2): 289-91
Pubmed [2548]
Paulzen M. J Affect Disord. Nov 2017; 227: 506-511
Pubmed [4750]
Paulzen M. J Clin Psychopharmacol. Feb 2016; 36(1): 90-2
Pubmed [2445]
Paulzen M. J Psychopharmacol. Aug 2016; 30(8): 803-9
Pubmed [4850]
Paulzen M. Pharmacopsychiatry. Nov 2011; 44(7): 317-23
Pubmed [2524]
Paulzen M. Prog Neuropsychopharmacol Biol Psychiatry. Apr 2018
Pubmed [4948]
Paulzen M. Prog Neuropsychopharmacol Biol Psychiatry. Jun 2017; 76: 101-106
Pubmed [13709]
Pautola L. Duodecim. Jan 2012; 128(10): 1031-2
Pubmed [9989]
Pauwels O. Pharmacol Res. Apr 2002; 45(4): 291-8
Pubmed [5827]
Pavelic AR. Cells. Dec 2022; 12(1)
Pubmed [13501]
Pawar PS. Am J Geriatr Pharmacother. Dec 2010; 8(6): 595-8
Pubmed [521]
Pawlowska M. Eur J Clin Pharmacol. Jun 2015; 71(6): 699-705
Pubmed [8046]
Pea F. Ann Pharmacother. Nov 2008; 42(11): 1711-6
Pubmed [5919]
Pea F. Antivir Ther. Jan 2008; 13(5): 739-42
Pubmed [7062]
Pea F. Clin Pharmacokinet. Jan 2001; 40(11): 833-68
Pubmed [7511]
Pea F. Transpl Infect Dis. Dec 2015; 17(6): 926-8
Pubmed [7017]
Peacock LE. Age Ageing. Jul 2011; 40(4): 528
Pubmed [3292]
Peano C. Ann Emerg Med. Nov 1997; 30(5): 704-8
Pubmed [2626]
Pearce RE. Drug Metab Dispos. Jun 2006; 34(6): 1035-40
Pubmed [4726]
Pearce RE. Drug Metab Dispos. Nov 2002; 30(11): 1170-9
Pubmed [74]
Pearlstein TB. J Clin Psychopharmacol. Aug 1997; 17(4): 261-6
Pubmed [13662]
Pecikoza U. Psychopharmacology (Berl). May 2020; 237(5): 1435-1446
Pubmed [11957]
Pecora Fulco P. Ann Pharmacother. Nov 2018; 52(11): 1165-1166
Pubmed [6669]
Pecora Fulco P. Ann Pharmacother. Sep 2003; 37(9): 1325-8
Pubmed [6709]
Pedersen JK. Ugeskr Laeger. Sep 2016; 178(39)
Pubmed [5917]
Pedersen KE. Acta Med Scand. Jan 1985; 218(2): 229-32
Pubmed [382]
Pedersen OL. Eur J Clin Pharmacol. Jan 1982; 23(6): 513-21
Pubmed [3321]
Pedraz-Petrozzi B. Clin Case Rep. Mar 2023; 11(3): e7045
Pubmed [12980]
Pedroso JL. Neurologist. Mar 2011; 17(2): 89-90
Pubmed [10587]
Peet CF. Eur J Drug Metab Pharmacokinet. Oct 2005; 30(4): 275-86
Pubmed [7985]
Peet M, Middlemiss DN, Yates RA. Pharmacocinetic interaction between propanolol and chlorpromazine in schizophrenic patients. Lancet (1980) ii, 978 [923]
Peet M, Middlemiss DN, Yates RA. Propanolol in schizophrenia II. Clinical and biochemical aspects of combining propanolol with chlorpromazine. Br J Psychiatry (1081) 138, 112-7 [924]
Peet M. Drug Saf. Feb 1995; 12(2): 146-53
Pubmed [8962]
Peeters M. Ann Pharmacother. Jun 2008; 42(6): 757-65
Pubmed [8455]
Peitz GJ. South Med J. Apr 2009; 102(4): 411-2
Pubmed [9537]
Pejčić AV. Int J Psychiatry Clin Pract. Mar 2022; 26(1): 29-42
Pubmed [12398]
Pelet A. Am J Drug Alcohol Abuse. Jul 2011; 37(4): 264-8
Pubmed [6307]
Pelkonen O. Arch Toxicol. Oct 2008; 82(10): 667-715
Pubmed [3716]
Pelkonen O. Toxicology. Apr 2000; 144(1-3): 139-47
Pubmed [4422]
Pellene A. Clin Neuropharmacol. Nov 2015; 38(6): 252-4
Pubmed [10394]
Pelton GH. Contemp Clin Trials. Mar 2014; 37(2): 200-8
Pubmed [13119]
Pelton GH. Int J Geriatr Psychiatry. Jun 2016; 31(6): 648-55
Pubmed [9951]
Peltoniemi MA. Clin Pharmacokinet. Sep 2016; 55(9): 1059-77
Pubmed [5159]
Peltoniemi MA. Eur J Clin Pharmacol. Jun 2012; 68(6): 979-86
Pubmed [3709]
Peña E. Brain Sci. Feb 2021; 11(2)
Pubmed [12227]
Peng B. Clin Pharmacokinet. Jan 2005; 44(9): 879-94
Pubmed [4899]
Pennachio D.L. Patient Care. Oct 2000; 34(19)
Pubmed [11617]
Penning-van Beest FJ. J Thromb Haemost. Feb 2008; 6(2): 284-90
Pubmed [9384]
Penninga EI. Basic Clin Pharmacol Toxicol. Jan 2016; 118(1): 37-44
Pubmed [5097]
Pentikäinen PJ et al. Acta Pharmacol Toxicol (1986) 59 (Suppl 5), 91 [2140]
Penttilå O. Br Med J. Jun 1974; 2(5917): 470-2
Pubmed , Volltext [5626]
Penzak et al. J Clin Psychopharmacol 2002;2(4):366-370 [3009]
Penzak SR. Am J Cardiovasc Drugs. Jan 2002; 2(2): 91-106
Pubmed [6901]
Penzak SR. J Acquir Immune Defic Syndr. Dec 2005; 40(5): 573-80
Pubmed [6476]
Penzak SR. Ther Drug Monit. Jun 2004; 26(3): 322-30
Pubmed [6416]
Penzner JB. J Child Adolesc Psychopharmacol. Oct 2009; 19(5): 563-73
Pubmed , Volltext , DOI [3280]
Perazella MA. Am J Med Sci. Jun 2003; 325(6): 349-62
Pubmed [5695]
Perdix (Moexipril), Schwarz Pharma Ltd. Summary of product characteristics, March 2000 [1734]
Pereira BB. J Toxicol Environ Health B Crit Rev. Apr 2020; : 1-5
Pubmed [8904]
Pereira MA. Rev Bras Anestesiol. Jan 1972; 22(1): 10-9
Pubmed [10000]
Peremans K. Nucl Med Commun. Aug 2008; 29(8): 724-9
Pubmed [4789]
Perez Ruixo JJ. J Clin Pharmacol. Mar 2015; 55 Suppl 3: S85-92
Pubmed [4017]
Perez-Lloret S. CNS Drugs. Aug 2016; 30(8): 703-17
Pubmed [10439]
Pérez-Torre P. Neurologia (Engl Ed). Sep 2021
Pubmed [12181]
Pergolizzi J. Pain Pract. Jul 2008; 8(4): 287-313
Pubmed [8991]
Pericàs JM. Clin Microbiol Infect. Jun 2018; 24(6): 673-676
Pubmed [8121]
Periclou A. Eur J Drug Metab Pharmacokinet. Jan 2021; 46(1): 53-69
Pubmed [11179]
Periclou A. J Clin Pharmacol. Apr 2010; 50(4): 422-33
Pubmed [3556]
Peritogiannis et al. (2007) J Clin Psychopharmacol 27(2):235-238 [2964]
Peritogiannis et al. Schizophr Res. 2005 Nov 15;79(2-3):345-6 [1471]
Peritogiannis V. Gen Hosp Psychiatry. May 2007; 29(3): 281-2
Pubmed [6237]
Peritogiannis V. Schizophr Res. Nov 2005; 79(2-3): 345-6
Pubmed [8963]
Bildrechte: © spinetta / Fotolia